Hasil Pencarian - Jacques Rouanet

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses

    Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses oleh Jacques Rouanet, Ines Joulie, Celine Lambert, Michel D'Incan

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms

    Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms oleh Hussein Akil, Jacques Rouanet, Claire Viallard, Sophie Besse, Philippe Auzeloux, Jean-Michel Chezal, Elisabeth Miot-Noirault, Mercedes Quintana, Françoise Degoul

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Assessment of 99mTc-NTP 15-5 uptake on cartilage, a new proteoglycan tracer: Study protocol for a phase I trial (CARSPECT)

    Assessment of 99mTc-NTP 15-5 uptake on cartilage, a new proteoglycan tracer: Study protocol for a phase I trial (CARSPECT) oleh Emilie Thivat, Emilie Thivat, Emilie Thivat, Marion Chanchou, Marion Chanchou, Sylvain Mathieu, Sophie Levesque, Sophie Levesque, Sophie Levesque, Tommy Billoux, Tommy Billoux, Philippe Auzeloux, Nicolas Sas, Nicolas Sas, Ioana Molnar, Ioana Molnar, Ioana Molnar, Elodie Jouberton, Elodie Jouberton, Jacques Rouanet, Jacques Rouanet, Giovanna Fois, Lydia Maigne, Marie-Josephe Galmier, Frédérique Penault-Llorca, Frédérique Penault-Llorca, Frédérique Penault-Llorca, Elisabeth Miot-Noirault, Xavier Durando, Xavier Durando, Xavier Durando, Xavier Durando, Florent Cachin, Florent Cachin, Florent Cachin

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol

    Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol oleh Emilie Thivat, Jacques Rouanet, Philippe Auzeloux, Nicolas Sas, Elodie Jouberton, Sophie Levesque, Tommy Billoux, Sandrine Mansard, Ioana Molnar, Marion Chanchou, Giovanna Fois, Lydia Maigne, Jean-Michel Chezal, Elisabeth Miot-Noirault, Michel D’Incan, Xavier Durando, Florent Cachin

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: